Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omiganan topical pharmacodynamic study with and without imiquimod in healthy volunteers
NL-OMON45716Active, not recruiting
- Sponsor
- Biofrontera
- Start
- Jan 2017
- Modality
- Small Molecules, Peptides, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of omiganan and imiquimod (4 arms), sponsored by Biofrontera. Primary endpoints: Local biopsy biomarkers, Histology and 8 more. Started Jan 2017; status: active, not recruiting.
02
Drugs
omigananimiquimod
Beyond the preview
Go deeper on NL-OMON45716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45716.